体外膜肺氧合治疗呼吸衰竭合并心力衰竭患者疗效分析:3例临床报告

Clinical application of ECMO treatment in patients with respiratory and heart failure in three cases

目的探讨体外膜肺氧合(ECMO)治疗3例呼吸衰竭合并心力衰竭患者的临床疗效。方法回顾性分析自2014年7至2015年4月收治的呼吸衰竭合并心力衰竭的3例患者的临床资料。行ECMO治疗,比较并分析患者治疗前后的呼吸频率、心率、平均动脉压(MAP)、二氧化碳分压(Pa CO_2)和血氧饱和度(Sp O_2)。结果ECMO治疗3 d后,患者心率下降至正常值,呼吸频率无明显变化,MAP下降至正常值,Pa CO_2下降至正常水平,Sp O_2增加至正常值,血流动力学平稳至正常。结论 ECMO对呼吸衰竭合并心力衰竭患者具有良好的治疗效果。

Objective To explore the curative efficacy of ECMO treatment in patients with respiratory and heart failure.Methods A retrospective study was performed on 3 cases with respiratory failure and heart failure treated via ECMO in the department of emergency medicine of The General Hospital of Shenyang Military Command from July 2014 to April 2015.Patient＇s respiratory rate（ RR）,heart rate（ HR）,mean arterial pressure（ MAP）,carbon dioxide partial pressure（ Pa CO2） and oxygen saturation（ Sp O2） were compared and analyzed between pre-operation and post-operation.Results After treatment of ECMO at 3 days,HR went down to normal,RR did not change significantly,MAP dropped to normal,Pa CO2 decreased to normal levels,Sp O2 increase to normal,and stable hemodynamics turned to normal in all 3 cases.Conclusion ECMO treatment for patients with respiratory failure and heart failure have a good therapeutic effect and prognosis.